Unknown NA INTERVENTIONAL 2-arm NCT05450042

Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation

Scientific Proposal to Substantiate Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation

Sponsor: University Hospital, Essen

Conditions Drug Eluting Balloon Flow-mediated Dilation Infrainguinal Peripheral Arterial Disease Peripheral Arterial Disease

Interventions Paclitaxel DCB SELUTION SLR DCB

Updated 5 times since 2022 Last updated: Dec 2, 2023 Started: Apr 6, 2022 Primary completion: Apr 6, 2024 Completion: Apr 6, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05450042, this NA trial focuses on Drug Eluting Balloon and Flow-mediated Dilation and remains ongoing. Sponsored by University Hospital, Essen, it has been updated 5 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Jan 2026 — Present [monthly]

Unknown NA

Status: Recruiting → Unknown
Sep 2024 — Jan 2026 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Jan 2024 — Jul 2024 [monthly]

Recruiting NA
Sep 2022 — Jan 2024 [monthly]

Recruiting NA

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Essen

Data source: University Hospital, Essen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Essen, Germany